INBX vs AMGN: Which Stock is Better?

Side-by-side comparison of Inhibrx Biosciences Inc and Amgen Inc in 2026

Comparison Updated:

INBX

Inhibrx Biosciences Inc

$88.23

AMGN

Amgen Inc

$355.30

Key Metrics Comparison

MetricINBXAMGNWinner
Market Cap$1.21B$188.34BAMGN
P/E RatioN/A24.57AMGN
EPS (TTM)$N/A$14.22AMGN
Revenue Growth-1.0%0.1%AMGN
Gross Margin-8594.5%70.8%AMGN

Analyze INBX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is INBX or AMGN a better investment?

Comparing INBX and AMGN: Inhibrx Biosciences Inc has a market cap of $1.21B while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between INBX and AMGN?

INBX (Inhibrx Biosciences Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: INBX or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: INBX or AMGN?

AMGN has higher revenue growth at 0.1% vs -1.0% for INBX.

Which company is more profitable: INBX or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -8594.5% for INBX.

Which is the larger company: INBX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $1.21B for INBX.

Should I buy INBX or AMGN in 2026?

Both INBX and AMGN have investment merit. INBX trades at $88.23 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between INBX and AMGN stock?

Key differences: Market Cap ($1.21B vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-8594.5% vs 70.8%).

Popular Stock Comparisons